FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
How to Better Harmonize Lab Test Results
Unharmonized and unstandardized test results can affect patient care. Here are steps that clinical labs can take to resolve this problem
Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Expert Q&A: The Latest in Breath Biopsy
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
Addressing the Challenges of Bile Acid Diarrhea Diagnosis
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Can Ophthalmic Biomarkers Offer Insights into Brain Pathologies?
Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.
Simplifying At-Home Tests with AI
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Combating Cervical Cancer: Where Do We Stand?
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
The Diagnostics Pipeline: FDA Launches Pilot for Cancer Companion Diagnostic LDTs
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Genetic and Multiorgan Imaging Approach Reveals Heart–Brain Connections
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
The Diagnostics Pipeline: First FDA Approval of CRISPR Therapy Possible This Year
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.
Making Complete Genome Sequencing Affordable, Accessible
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Emerging Polygenic Risk Score Tests Demonstrate Potential for Improving Cancer Screening
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
